Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. (Q48192706)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. |
scientific article |
Statements
1 reference
Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. (English)
1 reference
1 reference
1 reference
Diana Bilton
1 reference
Evangelia Daviskas
1 reference
John Kolbe
1 reference
Gregory King
1 reference
Rob G Stirling
1 reference
David Milne
1 reference
Brett Charlton
1 reference
B301 Investigators
1 reference
1 July 2013
1 reference
1 reference
144
1 reference
1
1 reference
215-225
1 reference
Identifiers
1 reference
1 reference